2022 American Transplant Congress
Simultaneous Liver/ Kidney Transplant Reduces Both Donor Specific and Non-Donor Specific HLA Antibodies
Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Kidney allografts can be transplanted across strong donor specific antibody (DSA) barriers in simultaneous liver/kidney transplant (SLK) recipients. It is suggested that preformed DSAs…2022 American Transplant Congress
Safety and Immunogenicity of Live Viral Vaccination After Pediatric Liver and Kidney Transplantation
*Purpose: New recommendations suggest that measles-mumps-rubella vaccine (MMR-vx) and varicella vaccine (VZV-vx) may be administered to certain non-immune transplant recipients. The purpose of this study…2022 American Transplant Congress
Clinical Outcomes In A Large Transplant Cohort Hospitalized With COVID-19: Mycophenolate Mofetil (MMF) Utilization And Mortality Trends
*Purpose: To characterize demographics, treatment patterns, and outcomes among 3,998 transplant patients hospitalized for COVID-19 over 16 months of the pandemic (May ’20-Aug ’21).*Methods: Adult…2022 American Transplant Congress
CD209+ Macrophages-Mediated Immunosuppressive Effects in ADPKD Tissues
*Purpose: The intensity of maintenance immunosuppression required in autosomal dominant polycystic kidney disease (ADPKD) patients after renal transplantation is lower than average, suggesting a reduced…2022 American Transplant Congress
De Novo Lipoprotein-X Causing Hypercholesterolemia and Acute Kidney Injury (AKI) in Simultaneous Liver Kidney Transplant (SLKT) Patient
*Purpose: Cholestasis can cause reflux and spillage of biliary lipid into the plasma which can combine with albumin forming lipoprotein-X. Severe hypercholesterolemia mediated by lipoprotein-X…2022 American Transplant Congress
Current State of Use of Hepatitis C Viremic Donor Organs in Negative Recipients in the United States: A National Survey
*Purpose: Since the advent of direct-acting antiviral (DAA) therapy, use of hepatitis C (HCV) viremic donor organs in HCV negative recipients has become more common.…2022 American Transplant Congress
Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation
Nephrology and Hypertension, Mayo Clinic, Rochester, MN
*Purpose: To demonstrate the role of simultaneous liver kidney transplant in PH2*Methods: A 30-year-old white man presented to our center for evaluation of chronic kidney…2022 American Transplant Congress
Impact of a Transplant Pharmacy Collaborative Practice Agreement Implementation on an Institutional Medication Assistance Program Funding Utilization
*Purpose: Post-transplant medication cost can pose a significant barrier for patient adherence and graft outcomes. Strategic selection of medication agent is often challenging and requires…2022 American Transplant Congress
Post-Allocation Policy and Changes in Gender Disparities in Access to Simultaneous Liver and Kidney Transplantation
*Purpose: Gender-based differences in receiving simultaneous liver-kidney transplant (SLKT) is not well-understood. We recently found that women are disadvantaged in access to SLKT, especially women…2022 American Transplant Congress
Barriers to Completing the Transplant Evaluation Process: A Mixed-Methods Study
*Purpose: Little is known about patient-reported factors affecting patients’ access to the kidney transplant waitlist after starting evaluation. We qualitatively assessed patients’ perceived barriers to…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 24
- Next Page »